The Cooper Companies, Inc. (COO) Stock Analysis
Falling Knife setup · Catalyst-Driven edge
Healthcare · Medical Instruments & Supplies
Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $63.17 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Below 200-day MA.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that... Read more
Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $63.17 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Below 200-day MA. Chart setup: Death cross, below all MAs, RSI 22, MACD bearish. Score 5.2/10, moderate confidence.
Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 28d clear, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $63.17 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Below 200-day MA. Chart setup: Death cross, below all MAs, RSI 22, MACD bearish. Prior stop was $59.60. Score 5.2/10, moderate confidence.
Take-profit target: $81.96 (+29.4% upside). Prior stop was $59.60. Stop-loss: $59.60.
Negative momentum; Below 200-day MA.
The Cooper Companies, Inc. trades at a P/E of 30.5 (forward 12.2). TrendMatrix value score: 6.8/10. Verdict: Sell.
25 analysts cover COO with a consensus score of 3.8/5. Average price target: $91.
What does The Cooper Companies, Inc. do?The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers....
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.